$JLL
JONES LANG LASALLE INC Stock $jll

$jll Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000103797624000021 Filed on May 06, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$5.629B	$5.125B
YoY Change	11.4%	8.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.403B	$4.948B
YoY Change	11.82%	7.45%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$62.30M	$61.00M
YoY Change	4.01%	6.09%
% of Gross Profit
Operating Expenses	$5.476B	$5.010B
YoY Change	11.69%	6.65%
Operating Profit	$152.4M	$114.2M
YoY Change	2.14%	541.57%
Interest Expense	-$57.10M	-$34.20M
YoY Change	-60.35%	18.34%
% of Operating Profit	-37.47%	-29.95%
Other Income/Expense, Net	$9.700M	$1.500M
YoY Change	-908.33%	1400.0%
Pretax Income	$105.0M	$81.50M
YoY Change	2525.0%	-840.91%
Income Tax	$20.50M	$15.90M
% Of Pretax Income	19.52%	19.51%
Net Earnings	$84.40M	$66.10M
YoY Change	3276.0%	-818.48%
Net Earnings / Revenue	1.5%	1.29%
Basic Earnings Per Share	$1.77	$1.39
Diluted Earnings Per Share	$1.75	$1.37
COMMON SHARES
Basic Shares Outstanding	47.56M shares	47.44M shares
Diluted Shares Outstanding	48.32M shares	48.28M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$424.4M	$396.7M
YoY Change	5.44%	-18.27%
Cash & Equivalents	$424.4M	$396.7M
Short-Term Investments
Other Short-Term Assets	$582.3M	$590.6M
YoY Change	-1.85%	-5.59%
Inventory
Prepaid Expenses
Receivables	$1.912B	$1.915B
Other Receivables	$3.406B	$3.090B
Total Short-Term Assets	$6.634B	$6.315B
YoY Change	-1.07%	-6.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$596.9M	$600.1M
YoY Change	1.95%	2.37%
Goodwill	$4.609B	$4.569B
YoY Change	0.69%	0.55%
Intangibles	$743.9M	$762.6M
YoY Change	-9.4%	-8.46%
Long-Term Investments	$819.7M	$816.2M
YoY Change	-6.07%	-8.91%
Other Assets	$204.2M	$204.7M
YoY Change	16.55%	18.26%
Total Long-Term Assets	$9.275B	$9.167B
YoY Change	1.7%	0.99%
TOTAL ASSETS
Total Short-Term Assets	$6.634B	$6.315B
Total Long-Term Assets	$9.275B	$9.167B
Total Assets	$15.91B	$15.48B
YoY Change	0.53%	-2.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.154B	$1.233B
YoY Change	9.43%	11.01%
Accrued Expenses	$1.254B	$1.251B
YoY Change	-3.98%	-2.52%
Deferred Revenue
YoY Change
Short-Term Debt	$126.2M	$124.6M
YoY Change	12.58%	19.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.514B	$5.099B
YoY Change	0.42%	-3.15%
LONG-TERM LIABILITIES
Long-Term Debt	$2.030B	$2.152B
YoY Change	-8.61%	-12.85%
Other Long-Term Liabilities	$424.4M	$425.7M
YoY Change	9.78%	4.21%
Total Long-Term Liabilities	$424.4M	$425.7M
YoY Change	9.78%	4.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.514B	$5.099B
Total Long-Term Liabilities	$424.4M	$425.7M
Total Liabilities	$9.411B	$9.075B
YoY Change	-2.31%	-6.32%
SHAREHOLDERS EQUITY
Retained Earnings	$5.942B	$5.858B
YoY Change	6.72%	5.23%
Common Stock	$2.014B	$1.976B
YoY Change	-0.1%	-0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$913.6M	$901.2M
YoY Change	1.99%	2.0%
Treasury Stock Shares
Shareholders Equity	$6.379B	$6.294B
YoY Change
Total Liabilities & Shareholders Equity	$15.91B	$15.48B
YoY Change	0.53%	-2.31%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$84.40M	$66.10M
YoY Change	3276.0%	-818.48%
Depreciation, Depletion And Amortization	$62.30M	$61.00M
YoY Change	4.01%	6.09%
Cash From Operating Activities	$273.9M	-$677.5M
YoY Change	15.57%	-5.42%
INVESTING ACTIVITIES
Capital Expenditures	$38.20M	$43.20M
YoY Change	-1.8%	-12.37%
Acquisitions
YoY Change
Other Investing Activities	-$61.60M	-$600.0K
YoY Change	28.87%	-154.55%
Cash From Investing Activities	-$99.80M	-$54.30M
YoY Change	15.11%	-26.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-136.8M	$703.4M
YoY Change	-49.59%	-9.27%
NET CHANGE
Cash From Operating Activities	273.9M	-$677.5M
Cash From Investing Activities	-99.80M	-$54.30M
Cash From Financing Activities	-136.8M	$703.4M
Net Change In Cash	37.30M	-$38.10M
YoY Change	-130.8%	262.86%
FREE CASH FLOW
Cash From Operating Activities	$273.9M	-$677.5M
Capital Expenditures	$38.20M	$43.20M
Free Cash Flow	$235.7M	-$720.7M
YoY Change	18.98%	-5.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16700000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17800000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-30500000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-26300000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2415600000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2253000000	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2532000000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2351500000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	61000000.0	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	57500000	usd
CY2024Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	1700000	usd
CY2023Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	35700000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	5010300000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	4697700000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	114200000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3700000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2600000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1500000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	100000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	81500000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11000000.0	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2300000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	65600000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-8700000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-500000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	500000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	66100000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9200000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47485000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47555000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.37
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48280000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47555000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	66100000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9200000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-300000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-37700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	26800000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28700000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17600000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6409900000	usd
CY2024Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	65600000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-20300000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11200000	usd
CY2024Q1	jll	Increase Decrease In Common Stock Held In Trust IncreaseDecreaseInCommonStockHeldInTrust	100000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	20000000.0	usd
CY2024Q1	jll	Change In Pension Liabilities Net Of Tax So Eqtd ChangeInPensionLiabilitiesNetOfTaxSoEQTD	300000	usd
CY2024Q1	jll	Foreign Currency Translation Adjustments So Eqtd ForeignCurrencyTranslationAdjustmentsSoEQTD	-37700000	usd
CY2024Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-1500000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6407600000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6142500000	usd
CY2023Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-8700000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-21400000	usd
CY2023Q1	jll	Foreign Currency Translation Adjustments So Eqtd ForeignCurrencyTranslationAdjustmentsSoEQTD	26800000	usd
CY2023Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-700000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6155200000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	65600000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-8700000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	61000000.0	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	57500000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3700000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2600000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3200000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3800000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9900000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7100000	usd
CY2024Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	11200000	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	16700000	usd
CY2024Q1	jll	Net Non Cash Mortgage Servicing Rights And Mortgage Banking Derivative Activity NetNonCashMortgageServicingRightsAndMortgageBankingDerivativeActivity	-9000000.0	usd
CY2023Q1	jll	Net Non Cash Mortgage Servicing Rights And Mortgage Banking Derivative Activity NetNonCashMortgageServicingRightsAndMortgageBankingDerivativeActivity	-1800000	usd
CY2024Q1	us-gaap	Accretion Expense AccretionExpense	1400000	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	1000000.0	usd
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-8600000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	900000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-156200000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-160600000	usd
CY2024Q1	jll	Increase Decreasein Reimbursable Receivablesand Reimbursable Payables IncreaseDecreaseinReimbursableReceivablesandReimbursablePayables	-193400000	usd
CY2023Q1	jll	Increase Decreasein Reimbursable Receivablesand Reimbursable Payables IncreaseDecreaseinReimbursableReceivablesandReimbursablePayables	-181600000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	18700000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	26500000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	24400000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	43700000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-154500000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-56000000.0	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-599100000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-651800000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-677500000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-716300000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	43200000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	49300000	usd
CY2024Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	17400000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	32800000	usd
CY2024Q1	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	5700000	usd
CY2023Q1	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	9200000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-600000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1100000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54300000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-74000000.0	usd
CY2024Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	2760000000	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	2668000000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1990000000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1793000000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-18700000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-62300000	usd
CY2024Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	3100000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	13600000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20000000.0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2024Q1	jll	Noncontrolling Interest Distributions Contributions Net NoncontrollingInterestDistributionsContributionsNet	-1500000	usd
CY2023Q1	jll	Noncontrolling Interest Distributions Contributions Net NoncontrollingInterestDistributionsContributionsNet	0	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-23300000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-23800000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	703400000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	775300000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9700000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4500000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-38100000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10500000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	663400000	usd
CY2024Q1	jll	Equity Losses Jll Technologies And La Salle EquityLossesJLLTechnologiesAndLaSalle	-4900000	usd
CY2023Q1	jll	Equity Losses Jll Technologies And La Salle EquityLossesJLLTechnologiesAndLaSalle	-3900000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	746000000.0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	625300000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	735500000	usd
CY2024Q1	jll	Restricted Cashbeginningofperiod RestrictedCashbeginningofperiod	253400000	usd
CY2023Q1	jll	Restricted Cashbeginningofperiod RestrictedCashbeginningofperiod	226700000	usd
CY2024Q1	jll	Restricted Cashendofperiod RestrictedCashendofperiod	228600000	usd
CY2023Q1	jll	Restricted Cashendofperiod RestrictedCashendofperiod	250100000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	22900000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	23900000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-41300000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-34800000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	48700000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	47200000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	375500000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	402300000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	1700000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	1800000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	373800000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	400500000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	146600000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	166200000	usd
CY2024Q1	jll	Percentageof Revenue Remaining Performance Obligation PercentageofRevenueRemainingPerformanceObligation	0.05
CY2024Q1	jll	Adjusted Ebitda AdjustedEBITDA	187100000	usd
CY2023Q1	jll	Adjusted Ebitda AdjustedEBITDA	112900000	usd
CY2024Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	1700000	usd
CY2023Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	35700000	usd
CY2024Q1	jll	Interest On Employee Loans Net InterestOnEmployeeLoansNet	1000000.0	usd
CY2023Q1	jll	Interest On Employee Loans Net InterestOnEmployeeLoansNet	-200000	usd
CY2024Q1	jll	Net Non Cash Msr And Mortgage Banking Derivative Activity NetNonCashMSRAndMortgageBankingDerivativeActivity	-9000000.0	usd
CY2023Q1	jll	Net Non Cash Msr And Mortgage Banking Derivative Activity NetNonCashMSRAndMortgageBankingDerivativeActivity	-1800000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-30500000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-26300000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2300000	usd
CY2024Q1	jll	Depreciation And Amortization Adjusted DepreciationAndAmortizationAdjusted	60000000.0	usd
CY2023Q1	jll	Depreciation And Amortization Adjusted DepreciationAndAmortizationAdjusted	56500000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	66100000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9200000	usd
CY2024Q1	jll	Paymentfor Contingent Consideration Liability Total PaymentforContingentConsiderationLiabilityTotal	3100000	usd
CY2023Q1	jll	Paymentfor Contingent Consideration Liability Total PaymentforContingentConsiderationLiabilityTotal	13800000	usd
CY2024Q1	jll	Number Of Acquisitions Subject To Potential Earn Out Payments Provisions NumberOfAcquisitionsSubjectToPotentialEarnOutPaymentsProvisions	12	acquisition
CY2023Q4	jll	Number Of Acquisitions Subject To Potential Earn Out Payments Provisions NumberOfAcquisitionsSubjectToPotentialEarnOutPaymentsProvisions	14	acquisition
CY2024Q1	jll	Business Combination Contingent Consideration Arrangements Range Of Outcomes High Value BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesHighValue	99700000	usd
CY2023Q4	jll	Business Combination Contingent Consideration Arrangements Range Of Outcomes High Value BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesHighValue	100000000.0	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4569100000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	714000000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	48600000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4587400000	usd
CY2024Q1	jll	Goodwill Additions Net Of Adjustments GoodwillAdditionsNetOfAdjustments	0	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-18300000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4569100000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4528000000	usd
CY2023Q1	jll	Goodwill Additions Net Of Adjustments GoodwillAdditionsNetOfAdjustments	0	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	15900000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	4543900000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1348000000	usd
CY2024Q1	jll	Finite And Indefinite Lived Intangible Assets Additions FiniteAndIndefiniteLivedIntangibleAssetsAdditions	21900000	usd
CY2024Q1	jll	Adjustment For Fully Amortized Intangibles AdjustmentForFullyAmortizedIntangibles	-14500000	usd
CY2024Q1	jll	Finite And Indefinite Lived Intangible Assets Translation Adjustments FiniteAndIndefiniteLivedIntangibleAssetsTranslationAdjustments	2200000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1353200000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	563000000.0	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	42700000	usd
CY2024Q1	jll	Accumulated Amortization Adjustmentforfully Amortized Intangibles AccumulatedAmortizationAdjustmentforfullyAmortizedIntangibles	-14500000	usd
CY2024Q1	jll	Accumulated Amortization Finite Lived Intangible Assets Translation Adjustments AccumulatedAmortizationFiniteLivedIntangibleAssetsTranslationAdjustments	600000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	590600000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	762600000	usd
CY2024Q1	us-gaap	Servicing Asset At Amortized Cost Other Than Temporary Impairments ServicingAssetAtAmortizedCostOtherThanTemporaryImpairments	1600000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1304300000	usd
CY2023Q1	jll	Finite And Indefinite Lived Intangible Assets Additions FiniteAndIndefiniteLivedIntangibleAssetsAdditions	17300000	usd
CY2023Q1	jll	Adjustment For Fully Amortized Intangibles AdjustmentForFullyAmortizedIntangibles	-9400000	usd
CY2023Q1	jll	Finite And Indefinite Lived Intangible Assets Translation Adjustments FiniteAndIndefiniteLivedIntangibleAssetsTranslationAdjustments	-1300000	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1313500000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	445800000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43600000	usd
CY2023Q1	jll	Accumulated Amortization Adjustmentforfully Amortized Intangibles AccumulatedAmortizationAdjustmentforfullyAmortizedIntangibles	-9400000	usd
CY2023Q1	jll	Accumulated Amortization Finite Lived Intangible Assets Translation Adjustments AccumulatedAmortizationFiniteLivedIntangibleAssetsTranslationAdjustments	-400000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	480400000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	833100000	usd
CY2023Q1	us-gaap	Servicing Asset At Amortized Cost Other Than Temporary Impairments ServicingAssetAtAmortizedCostOtherThanTemporaryImpairments	2900000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	816200000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	816600000	usd
CY2024Q1	jll	Number Of Separate Property Or Fund Co Investments NumberOfSeparatePropertyOrFundCoInvestments	49	investment
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	740800000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	794900000	usd
CY2024Q1	jll	Investmentsin Real Estate Venturesat Fair Value Additions InvestmentsinRealEstateVenturesatFairValueAdditions	18800000	usd
CY2023Q1	jll	Investmentsin Real Estate Venturesat Fair Value Additions InvestmentsinRealEstateVenturesatFairValueAdditions	32800000	usd
CY2024Q1	jll	Investmentsin Real Estate Venturesat Fair Value Distributions InvestmentsinRealEstateVenturesatFairValueDistributions	6400000	usd
CY2023Q1	jll	Investmentsin Real Estate Venturesat Fair Value Distributions InvestmentsinRealEstateVenturesatFairValueDistributions	6600000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3100000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3300000	usd
CY2024Q1	jll	Investmentsin Real Estate Venturesat Fair Value Foreign Currency Translation InvestmentsinRealEstateVenturesatFairValueForeignCurrencyTranslation	-6300000	usd
CY2023Q1	jll	Investmentsin Real Estate Venturesat Fair Value Foreign Currency Translation InvestmentsinRealEstateVenturesatFairValueForeignCurrencyTranslation	7700000	usd
CY2024Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	743800000	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	825500000	usd
CY2024Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	795200000	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	798100000	usd
CY2024Q1	us-gaap	Senior Long Term Notes SeniorLongTermNotes	770200000	usd
CY2023Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	779300000	usd
CY2024Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	2100000000	usd
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	2070000000.00	usd
CY2024Q1	jll	Foreign Currency Forward Contract Net Notional Value ForeignCurrencyForwardContractNetNotionalValue	1160000000	usd
CY2023Q4	jll	Foreign Currency Forward Contract Net Notional Value ForeignCurrencyForwardContractNetNotionalValue	1210000000	usd
CY2024Q1	us-gaap	Common Stock Issued Employee Stock Trust CommonStockIssuedEmployeeStockTrust	10300000	usd
CY2023Q4	us-gaap	Common Stock Issued Employee Stock Trust CommonStockIssuedEmployeeStockTrust	10400000	usd
CY2024Q1	us-gaap	Bank Overdrafts BankOverdrafts	10400000	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	13400000	usd
CY2024Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	114200000	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	134500000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	124600000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	147900000	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	2276200000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1537800000	usd
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	400000	usd
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	400000	usd
CY2024Q1	jll	Uncommitted Facility Maximum Borrowing Capacity UncommittedFacilityMaximumBorrowingCapacity	400000000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	54200000	usd
CY2024Q1	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	322200000	usd
CY2023Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	662700000	usd
CY2024Q1	jll	Level Of Risk Retained Per Claim LevelOfRiskRetainedPerClaim	10000000	usd
CY2023Q4	us-gaap	Loss Contingency Receivable LossContingencyReceivable	2500000	usd
CY2024Q1	us-gaap	Loss Contingency Receivable LossContingencyReceivable	2500000	usd
CY2024Q1	jll	Loansubjecttolosssharingarrangementsaggregateunpaidprincipalamount Loansubjecttolosssharingarrangementsaggregateunpaidprincipalamount	21400000000	usd
CY2023Q4	jll	Loansubjecttolosssharingarrangementsaggregateunpaidprincipalamount Loansubjecttolosssharingarrangementsaggregateunpaidprincipalamount	20800000000	usd
CY2024Q1	jll	Loanlossaccrual Loanlossaccrual	31600000	usd
CY2023Q4	jll	Loanlossaccrual Loanlossaccrual	30900000	usd
CY2024Q1	jll	Loanlossguaranteereserve Loanlossguaranteereserve	24900000	usd
CY2023Q4	jll	Loanlossguaranteereserve Loanlossguaranteereserve	23400000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	300000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1800000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-10500000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2024Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	1700000	usd
CY2023Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	35700000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
jll-20240331_cal.xml	Edgar Link	unprocessable
0001037976-24-000021-index-headers.html	Edgar Link	pending
0001037976-24-000021-index.html	Edgar Link	pending
0001037976-24-000021.txt	Edgar Link	pending
0001037976-24-000021-xbrl.zip	Edgar Link	pending
exhibit101.htm	Edgar Link	pending
exhibit101001.jpg	Edgar Link	pending
exhibit101002.jpg	Edgar Link	pending
exhibit101003.jpg	Edgar Link	pending
exhibit101004.jpg	Edgar Link	pending
exhibit101005.jpg	Edgar Link	pending
exhibit101006.jpg	Edgar Link	pending
exhibit101007.jpg	Edgar Link	pending
exhibit101008.jpg	Edgar Link	pending
exhibit101009.jpg	Edgar Link	pending
exhibit101010.jpg	Edgar Link	pending
exhibit101011.jpg	Edgar Link	pending
exhibit101012.jpg	Edgar Link	pending
exhibit101013.jpg	Edgar Link	pending
exhibit101014.jpg	Edgar Link	pending
exhibit101015.jpg	Edgar Link	pending
exhibit101016.jpg	Edgar Link	pending
exhibit101017.jpg	Edgar Link	pending
exhibit101018.jpg	Edgar Link	pending
exhibit101019.jpg	Edgar Link	pending
exhibit101020.jpg	Edgar Link	pending
exhibit101021.jpg	Edgar Link	pending
exhibit101022.jpg	Edgar Link	pending
exhibit101023.jpg	Edgar Link	pending
exhibit101024.jpg	Edgar Link	pending
exhibit101025.jpg	Edgar Link	pending
exhibit101026.jpg	Edgar Link	pending
exhibit101027.jpg	Edgar Link	pending
exhibit101028.jpg	Edgar Link	pending
exhibit101029.jpg	Edgar Link	pending
exhibit101030.jpg	Edgar Link	pending
exhibit101031.jpg	Edgar Link	pending
exhibit101032.jpg	Edgar Link	pending
exhibit101033.jpg	Edgar Link	pending
exhibit101034.jpg	Edgar Link	pending
exhibit101035.jpg	Edgar Link	pending
exhibit101036.jpg	Edgar Link	pending
exhibit101037.jpg	Edgar Link	pending
exhibit101038.jpg	Edgar Link	pending
exhibit101039.jpg	Edgar Link	pending
exhibit101040.jpg	Edgar Link	pending
exhibit101041.jpg	Edgar Link	pending
exhibit101042.jpg	Edgar Link	pending
exhibit101043.jpg	Edgar Link	pending
exhibit101044.jpg	Edgar Link	pending
exhibit101045.jpg	Edgar Link	pending
exhibit101046.jpg	Edgar Link	pending
exhibit101047.jpg	Edgar Link	pending
exhibit101048.jpg	Edgar Link	pending
exhibit102.htm	Edgar Link	pending
exhibit102001.jpg	Edgar Link	pending
exhibit102002.jpg	Edgar Link	pending
exhibit102003.jpg	Edgar Link	pending
exhibit102004.jpg	Edgar Link	pending
exhibit102005.jpg	Edgar Link	pending
exhibit102006.jpg	Edgar Link	pending
exhibit102007.jpg	Edgar Link	pending
exhibit102008.jpg	Edgar Link	pending
exhibit103.htm	Edgar Link	pending
exhibit104.htm	Edgar Link	pending
exhibit311-jllq12024.htm	Edgar Link	pending
exhibit312-jllq12024.htm	Edgar Link	pending
exhibit32-jllq12024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
jll-20240331.htm	Edgar Link	pending
jll-20240331.xsd	Edgar Link	pending
jll-20240331_g1.jpg	Edgar Link	pending
jll-20240331_g2.jpg	Edgar Link	pending
jll-20240331_g3.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
jll-20240331_def.xml	Edgar Link	unprocessable
jll-20240331_lab.xml	Edgar Link	unprocessable
jll-20240331_pre.xml	Edgar Link	unprocessable
jll-20240331_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JLL
JONES LANG LASALLE INC Stock $jll

2024 Q2 Form 10-Q Financial Statement

#000103797624000021 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JLL JONES LANG LASALLE INC Stock $jll

2024 Q2 Form 10-Q Financial Statement

#000103797624000021 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JLL
JONES LANG LASALLE INC Stock $jll